Stacytine 600

Stacytine 600 reduces the viscosity of purulent and non purulent pulmonary secretions. Acetylcysteine may also protect the liver in case of overdose of paracetamol.

Pack size Box of 01 tube of 10 tablets. Box of 16 tablets (4 strips x 4 tablets)
Shelf-life 36 months
Composition Acetylcysteine
Dosage forms and strengths Effervescent tablet: 600 mg
Product code :



  • For use as a mucolytic in respiratory disorders such as in bronchitis, emphysema, mucoviscidoses and bronchiectasis.
  • For adults only.


  • Adults: 600 mg acetylcysteine once daily.


  • Before oral use the tablet should be dissolved in half a glass of water.
  • For patients with a reduced cough reflex (elderly and weakened patients) are advised to take the effervescent tablet in the mornings.
  • Stacytine 600 is contraindicated in children 0 to 2 years.
  • Children older than 2 years of age and adolescents: The safety and efficacy is not established. Other forms and strengths of acetylcysteine are more suitable.
  • Hypersensitivity to acetylcysteine or to any of the excipients.
  • Children under 2 years of age.
  • Hypersensitivity reactions (bronchospasm, dyspnoea, pruritus, urticaria, rash, angioedema and tachycardia).
  • Low blood pressure.
  • Bronchospasms may occur with the use of acetylcysteine. If bronchospasm occur, the medicinal product should be discontinued immediately.
  • Caution is advised in patients with a history of peptic ulcer, especially when used concomitantly with other medicinal products known to irritate the mucous membrane of the gastrointestinal tract.
  • If cutaneous or mucosal alterations newly occur, immediate medical advice should be sought and the treatment with acetylcysteine should be discontinued immediately.
  • Bronchial secretions may become more fluid and increase in volume, in particular at the start of the treatment with acetylcysteine. When a patient is unable to cough up the secretions effectively, postural drainage and bronchoaspiration should be performed.
  • Stacytine 600 contains sorbitol. Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product.
  • Stacytine 600 contains aspartame, may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
  • Stacytine 600 contains 80 mg sodium benzoate which may increase jaundice (yellowing of the skin and eyes) in newborn babies (up to 4 weeks old)
  • Stacytine 600 may be used during pregnancy and breastfeeding.
  • Patients should be aware of how they react to drug before driving or operating machinery.